Glycine
USITC Makes Determination in Five-Year (Sunset) Review Concerning Glycine From China
The U.S. International Trade Commission (USITC) today determined that revoking the existing antidumping duty order on imports of glycine from China would be likely to lead to continuation or recurrence of material injury within a reasonably foreseeable time.
As a result of the Commission’s affirmative determination, the existing order on imports of this product from China will remain in place.
Chairman David S. Johanson and Commissioners Rhonda K. Schmidtlein, Jason E. Kearns and Randolph J. Stayin voted in the affirmative. Commissioner Amy A. Karpel did not participate in the vote for this review.
Today’s action comes under the five-year (sunset) review process required by the Uruguay Round Agreements Act. See the attached page for background on these five-year (sunset) review.
The Commission’s public report Glycine from China (Inv. No. 731-TA-718 (Fifth Review), USITC Publication 5347, August 2022) will contain the views of the Commission and information developed during the review.
The report will be available by September 13, 2022; when available, it may be accessed on the USITC website at: https://www.usitc.gov/commission_publications_library.
BACKGROUND
The Uruguay Round Agreements Act requires the Department of Commerce to revoke an antidumping or countervailing duty order, or terminate a suspension agreement, after five years unless the Department of Commerce and the USITC determine that revoking the order or terminating the suspension agreement would be likely to lead to continuation or recurrence of dumping or subsidies (Commerce) and of material injury (USITC) within a reasonably foreseeable time.
The Commission’s institution notice in five-year reviews requests that interested parties file responses with the Commission concerning the likely effects of revoking the order under review as well as other information. Generally within 95 days from institution, the Commission will determine whether the responses it has received reflect an adequate or inadequate level of interest in a full review. If responses to the USITC’s notice of institution are adequate, or if other circumstances warrant a full review, the Commission conducts a full review, which includes a public hearing and issuance of questionnaires.
The Commission generally does not hold a hearing or conduct further investigative activities in expedited reviews. Commissioners base their injury determination in expedited reviews on the facts available, including the Commission’s prior injury and review determinations, responses received to its notice of institution, data collected by staff in connection with the review, and information provided by the Department of Commerce.
The five-year (sunset) review concerning Glycine from China was instituted on January 3, 2022.
On April 8, 2022, the Commission voted to conduct an expedited review. Chairman David S. Johanson and Commissioners Rhonda K. Schmidtlein, Jason E. Kearns, Randolph J. Stayin, and Amy A. Karpel concluded that the domestic group response was adequate and the respondent group response was inadequate and voted for an expedited review.
A record of the Commission’s vote to conduct an expedited review is available from the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436. Requests may be made by telephone by calling 202-205-1802.
Glycine from Thailand Injures U.S. Industry, Says USITC
The United States International Trade Commission (USITC) today determined that a U.S. industry is materially injured by reason of imports of glycine from Thailand that the U.S. Department of Commerce (Commerce) has determined are sold in the United States at less than fair value.
Chairman David S. Johanson and Commissioners Rhonda K. Schmidtlein and Jason E. Kearns voted in the affirmative. Commissioners Randolph J. Stayin and Amy A. Karpel did not participate in these votes.
As a result of the USITC’s affirmative determination, Commerce will issue an antidumping duty order on imports of this product from Thailand.
The Commission’s public report Glycine from Thailand (Inv. No. 731-TA-1415 (Final), USITC Publication 4977, October 2019) will contain the views of the Commission and information developed during the investigation.
The report will be available by October 23, 2019; when available, it may be accessed on the USITC website at: https://www.usitc.gov/commission_publications_library.
UNITED STATES INTERNATIONAL TRADE COMMISSION
Washington, DC 20436
FACTUAL HIGHLIGHTS
Product Description: Glycine, also known as aminoacetic acid, is a nonessential amino acid (Chemical Abstracts Service registry number 56-40-6). The organic chemical is produced naturally by humans and other organisms as a building block for proteins. Commercial production of glycine uses traditional chemical synthesis. Glycine is most commonly sold in its dry form as a white, free flowing powder. Glycine is odorless and sweet to the taste. Available in various grades, glycine is used in industrial applications, as well as pharmaceutical and food applications.
Status of Proceedings:
- Type of investigation: Final phase antidumping duty investigation.
- Petitioners: Chattem and GEO.
- USITC Institution Date: Wednesday, March 28, 2018.
- USITC Hearing Date: Tuesday, April 30, 2019.
- USITC Vote Date: Wednesday, September 18, 2019.
- USITC Notification to Commerce Date: October 8, 2019.
U.S. Industry in 2017:
- Number of U.S. producers: 2
- Location of producers’ plants: Tennessee and Texas.
- Production and related workers: 1
- U.S. producers’ U.S. shipments: 1
- Apparent U.S. consumption: 1
- Ratio of imports from Thailand to apparent U.S. consumption: 1
U.S. Imports in 2017:
- U.S. imports from China, India, and Japan: $18.6 million.
- U.S. imports from Thailand: $4.6 million.
- U.S. imports from all other sources: $480,000.
- Leading import sources: China, India, Japan, and Thailand.
1Withheld to avoid disclosure of business proprietary information.
Glycine from China, India, and Japan Injures U.S. Industry, Says USITC
The United States International Trade Commission (USITC) today determined that a U.S. industry is materially injured by reason of imports of glycine from India and Japan that the U.S. Department of Commerce (Commerce) has determined are sold in the United States at less than fair value and imports that are subsidized by the governments of China and India.
Chairman David S. Johanson and Commissioners Irving A. Williamson, Meredith M. Broadbent, Rhonda K. Schmidtlein, and Jason E. Kearns voted in the affirmative.
As a result of the USITC’s affirmative determinations, Commerce will issue antidumping duty orders on imports of this product from India and Japan and countervailing duty orders on imports of this product from China and India.
The Commission’s public report Glycine from China, India, and Japan (Inv. Nos. 701-TA-603-604 and 731-TA-1413-1414 (Final), USITC Publication 4900, June 2019) will contain the views of the Commission and information developed during the investigations.
The report will be available by July 5, 2019; when available, it may be accessed on the USITC website at: https://www.usitc.gov/commission_publications_library.
UNITED STATES INTERNATIONAL TRADE COMMISSION
Washington, DC 20436
FACTUAL HIGHLIGHTS
Glycine from China, India, and Japan
Investigation Nos. 701-TA-603-604 and 731-TA-1413-1414 (Final)
Product Description: Glycine, also known as aminoacetic acid, is a nonessential amino acid (Chemical Abstracts Service registry number 56-40-6). The organic chemical is produced naturally by humans and other organisms as a building block for proteins. Commercial production of glycine uses traditional chemical synthesis. Glycine is most commonly sold in its dry form as a white, free flowing powder. Glycine is odorless and sweet to the taste. Available in various grades, glycine is used in industrial applications, as well as pharmaceutical and food applications.
Status of Proceedings:
1. Type of investigations: Final phase antidumping duty and countervailing duty investigations.
2. Petitioners: Chattem and GEO.
3. USITC Institution Date: Wednesday, March 28, 2018.
4. USITC Hearing Date: Tuesday, April 30, 2019.
5. USITC Vote Date: Wednesday, May 29, 2019.
6. USITC Notification to Commerce Date: Friday, June 14, 2019.
U.S. Industry in 2017:
1. Number of U.S. producers: 2.
2. Location of producers’ plants: Tennessee and Texas.
3. Production and related workers: [1]
4. U.S. producers’ U.S. shipments: 1
5. Apparent U.S. consumption: 1
6. Ratio of imports from China, India, and Japan to apparent U.S. consumption: 1
U.S. Imports in 2017:
1. U.S. imports from China, India, and Japan: $18.6 million.
2. U.S. imports from Thailand: $4.6 million.
3. U.S. imports from all other sources: $480,000.
4. Leading import sources: China, India, Japan, and Thailand.
[1] Withheld to avoid disclosure of business proprietary information.
USITC Makes Determinations in Five-Year (Sunset) Review Concerning Glycine from China
The U.S. International Trade Commission (USITC) today determined that revoking the existing antidumping duty order on Glycine from China would be likely to lead to continuation or recurrence of material injury within a reasonably foreseeable time.
As a result of the Commission’s affirmative determination, the existing antidumping duty order on imports of this product from China will remain in place.
All six Commissioners voted in the affirmative.
Today’s action comes under the five-year (sunset) review process required by the Uruguay Round Agreements Act. See the attached page for background on this five-year (sunset) review.
The Commission’s public report Glycine from China, Inv. No. 731-TA-718 (Fourth Review), (USITC Publication 4667, January 2017) will contain the views of the Commission and information developed during the review.
The report will be available by February 21, 2017; when available, it may be accessed on the USITC website at: http://pubapps.usitc.gov/applications/publogs/qry_publication_loglist.asp.
BACKGROUND
The Uruguay Round Agreements Act requires the Department of Commerce to revoke an antidumping or countervailing duty order, or terminate a suspension agreement, after five years unless the Department of Commerce and the USITC determine that revoking the order or terminating the suspension agreement would be likely to lead to continuation or recurrence of dumping or subsidies (Commerce) and of material injury (USITC) within a reasonably foreseeable time.
The Commission’s institution notice in five-year reviews requests that interested parties file responses with the Commission concerning the likely effects of revoking the order under review as well as other information. Generally within 95 days from institution, the Commission will determine whether the responses it has received reflect an adequate or inadequate level of interest in a full review. If responses to the USITC’s notice of institution are adequate, or if other circumstances warrant a full review, the Commission conducts a full review, which includes a public hearing and issuance of questionnaires.
The Commission generally does not hold a hearing or conduct further investigative activities in expedited reviews. Commissioners base their injury determination in expedited reviews on the facts available, including the Commission’s prior injury and review determinations, responses received to its notice of institution, data collected by staff in connection with the review, and information provided by the Department of Commerce.
The five-year (sunset) review concerning Glycine from China was instituted on August 1, 2016.
On November 4, 2016, the Commission voted to conduct an expedited review. All six Commissioners concluded that the domestic group response for this review was adequate and the respondent group response was inadequate and voted for an expedited review.
A record of the Commission’s vote to conduct an expedited review is available from the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436. Requests may be made by telephone by calling 202-205-1802.
USITC Will Expedite Its Five-Year (Sunset) Review Concerning Glycine from China
The U.S. International Trade Commission (USITC or Commission) has voted to expedite its five-year (“sunset”) review concerning the antidumping duty order on glycine from China.
As a result of the vote, the Commission will conduct an expedited review to determine whether revocation of the order would be likely to lead to continuation or recurrence of material injury within a reasonably foreseeable time.
The Uruguay Round Agreements Act requires the Department of Commerce to revoke an antidumping or countervailing duty order, or terminate a suspension agreement, after five years unless the Department of Commerce and the USITC determine that revoking the order or terminating the suspension agreement would be likely to lead to continuation or recurrence of dumping or subsidies (Commerce) and of material injury (USITC) within a reasonably foreseeable time.
The Commission’s notice of institution in five-year reviews requests that interested parties file with the Commission responses that discuss the likely effects of revoking the order under review and provide other pertinent information. Generally within 95 days from institution, the Commission will determine whether the responses it has received reflect an adequate or inadequate level of interest in a full review. If responses to the USITC's notice of institution are adequate, or if other circumstances warrant a full review, the Commission conducts a full review, which includes a public hearing and issuance of questionnaires.
The Commission generally does not hold a hearing or conduct further investigative activities in expedited reviews. Commissioners base their injury determinations in expedited reviews on the facts available, including the Commission’s prior injury and review determinations, responses received to its notice of institution, data collected by staff in connection with the reviews, and information provided by the Department of Commerce.
All six Commissioners concluded that the domestic group response for this review was adequate and the respondent group response was inadequate and voted for an expedited review.
A record of the Commission’s vote on this matter is available from the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436. Requests may be made by telephone by calling 202-205-1802.
The record of the Commission's vote is also posted on the USITC's Internet site at http://pubapps2.usitc.gov/sunset/caseProf/list?sort=caseTitle&order=asc. From this page, search "glycine" using the search box in the upper right corner.
The Federal Register notice will indicate whether any further information or statements will be available. Only parties that filed adequate responses and filed timely notices of appearance are eligible to participate further in this review. The Commission will issue a report after it completes its review.